Jeff Liter, CEO of Luminary Therapeutics, discusses the importance of demonstrating clinical evidence at the JP Morgan Healthcare Conference.
Jeff Liter
Advertisement
Articles by Jeff Liter
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Generates $1.5 Billion Stockpile of Orforglipron Ahead of FDA Decision
2
Pharmaceutical Executive Daily: Eli Lilly's $1.5 Billion Stockpile of Orforglipron
3
Pharm Exec's 2026 Pipeline Report: Next Frontiers in Focus
4
Bridging the Data Gap: How Digital Behavioral Insights Can Transform HCP Targeting in Specialty Care
5